SEC Form 4 · accession 0001209191-15-040524
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart Essig
Director
Period of report
May 7, 2015
Accepted (ET)
May 8, 2015 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 7, 2015 | M | 75,000 | $35.57 | A | 1,031,809 | D | |
| Common StockF1 | May 7, 2015 | S | 75,000 | $64.3227 | D | 956,809 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $35.57 | May 7, 2015 | M | 75,000 | D | — | Dec 19, 2015 | Common Stock | 75,000 | 0 | D |
Explanation of responses
- F1The price shown above represents the weighted average price of the shares sold. The range of the sale prices was $64.00 to $64.82.
- F225% of the option grant vested on 12/19/2006 (the first anniversary of the grant date of 12/19/2005), and the remaining 75% vested monthly thereafter over 36 months.